Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial.
Shi T, Jiang R, Yu J, Yang H, Tu D, Dai Z, Shen Y, Zhang Y, Cheng X, Jia H, Tu R, Wang H, Tang J, Luan Y, Cai S, Zang R; SGOG-OV/AICE Investigators.
Shi T, et al. Among authors: tang j.
Br J Cancer. 2018 Jul;119(1):12-18. doi: 10.1038/s41416-018-0036-7. Epub 2018 Jun 14.
Br J Cancer. 2018.
PMID: 29899395
Free PMC article.
Clinical Trial.